Essential Reads: What is the Best Screening Tool for Depression During Pregnancy?
Many women experience depression during pregnancy. What is the best way to identify these women?
Essential Reads: What is the Best Antidepressant to Use During Pregnancy?
The reality is that most of the antidepressants taken by women today are relatively safe and carry a very low risk to the developing fetus.
Reproductive safety of treatments for women with bipolar disorder
Dr. Lee S. Cohen, Director of the Ammon-Pinizzotto Center for Women's Mental Health at Massachusetts General Hospital, recently shared his insights on the reproductive safety of medication for bipolar disorder with Ob.Gyn News on March [...]
Reproductive psychiatry in 2021: Old questions and new challenges
Dr. Lee S. Cohen recently shared his insights on the practice of reproductive psychiatry during the COVID-19 pandemic with ObGyn News
Clinical Update 2020: Antipsychotic Medications and Risk of Gestational Diabetes
Given the number of younger women using atypical antipsychotic medications, there is an urgent need for more accurate data regarding the reproductive safety of these medications. One important question is whether these newer antipsychotic [...]
What is the Risk for Relapse After Stopping Antidepressants During Pregnancy?
For women taking antidepressants, how do we decide whether or not they should maintain their medication during pregnancy? Based on our previous research and clinical experiences, we know that many women who discontinue antidepressant [...]
How to Find Information on the Reproductive Safety of Medications
Last week, I met with a woman who was planning pregnancy. She had a long history of generalized anxiety disorder and panic disorder and had done very well over the past 10 years on [...]
Risk of Preterm Birth and Respiratory Distress in Pregnancies with Prenatal Exposure to Antidepressants
From the OptumLabs Data Warehouse, researchers identified 226,932 singleton deliveries. Cases of antidepressant exposure were defined as pregnancies with prescription claims for antidepressants submitted between the last menstrual period and 35 weeks’ gestation. To [...]
Reproductive psychiatry during the COVID-19 pandemic
Dr. Lee S. Cohen, Director of the Ammon-Pinizzotto Center for Women's Mental Health at Massachusetts General Hospital, recently shared his insights on the practice of reproductive psychiatry amidst the COVID-19 pandemic with Ob.Gyn News on [...]
Cognitive Development in Children Exposed to Levetiracetam (Keppra)
An increasing number of reproductive age women now take newer anticonvulsants for the treatment of mood and anxiety disorders; however, information regarding the reproductive safety of these medications is limited. A recent study has evaluated the cognitive and language development of children born to women with epilepsy exposed in utero to levetiracetam (LEV, Keppra) or sodium valproate (VPA, Depakote), as compared to control children born to women without epilepsy not taking medication during pregnancy.